TXMD
TXMD
NASDAQ · Pharmaceuticals

Therapeuticsmd Inc

$2.10
-0.09 (-4.11%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +465.7% upside
Low Target $7.57
Average Target $11.88
High Target $17.16
Current Price $2.10
Current
$2.10
Target
$11.88
$7.57 $11.88 avg $17.16
Scenario Analysis
Bear Case
$7.57
260.5%
Low target
Base Case
$11.88
+465.7%
Avg target
Bull Case
$17.16
+717.1%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$2.95
-28.8% from high
52-Week Low
$0.99
+112.1% from low
Target vs 52W High
$11.88
+302.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%